% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Hauptmann:828597,
      author       = {Hauptmann, Christian and Haller, Markus and Williams, Mark
                      and Vinciati, Federica},
      title        = {{T}echnical {F}easibility of {A}coustic {C}oordinated
                      {R}eset {T}herapy for {T}innitus {D}elivered via {H}earing
                      {A}ids: {A} {C}ase {S}tudy},
      journal      = {Case reports in otolaryngology},
      volume       = {2017},
      issn         = {2090-6765},
      address      = {New York, NY},
      publisher    = {Hindawi},
      reportid     = {FZJ-2017-02503},
      pages        = {5304242},
      year         = {2017},
      abstract     = {Primary tinnitus has a severe negative influence on the
                      quality of life of a substantial portion of the general
                      population. When acoustic coordinated reset (CR)
                      neuromodulation stimuli are delivered for several hours per
                      day over several weeks a clinically significant symptom
                      reduction in patients with primary tonal tinnitus has been
                      reported by several clinical sites. Here, we reported the
                      first case where CR neuromodulation was delivered through a
                      hearing aid. A 52-year-old man with chronic primary tonal
                      tinnitus was previously considered untreatable with sound
                      therapy. He initially received the classic CR treatment
                      protocol with signals delivered with the separate
                      proprietary device with his hearing aids removed during
                      treatment. He was subsequently treated with the therapy
                      being deployed through a set of contemporary hearing aids.
                      After 5 months of classic CR treatment with the separate
                      custom device, the THI and VASL/A scores worsened by $57\%$
                      and $13\%/14\%,$ respectively. Using the hearing aid without
                      CR treatment for 5 months no change in tinnitus symptoms was
                      observed. However, after three months of CR treatment
                      delivered through the hearing aids, the THI and VASL/A
                      scores were reduced by $70\%$ and $32\%/32\%,$
                      respectively.},
      cin          = {INM-7},
      ddc          = {610},
      cid          = {I:(DE-Juel1)INM-7-20090406},
      pnm          = {572 - (Dys-)function and Plasticity (POF3-572)},
      pid          = {G:(DE-HGF)POF3-572},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:28465850},
      UT           = {WOS:000397989300001},
      doi          = {10.1155/2017/5304242},
      url          = {https://juser.fz-juelich.de/record/828597},
}